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Summary. The role of 2-mercaptoethanol and in- 
domethacin the induction of lymphokine-activated killer 
(LAK) activity by interleukin-2 (IL-2) in rat splenocyte 
cultures was investigated. Spleens from 4-month-old male 
rats of five different strains were teste& Splenocytes were 
cultured for 3-5 days in the presence of IL-2 (1000 U/tal) 
and LAK activity was assessed by 4-h 51Cr release assays 
with P815 and YAC-1 cells as targets. LAK activity could 
be induced by IL-2 in splenocytes from all rat strains, but 
only when 2-mercaptoethanol was present in the culture 
medium. Optimal LAK activity was induced when the 
2-mercaptoethanol c ncentration i splenocyte cultures 
was at least 5 gM. Different rat strains howed ifferences 
in levels of in vitro induction of LAK activity. In the 
presence of 2-mercaptoethanol thelevel of LAK activity 
induced by IL-2 was high in BN and Lewis rats, interme- 
diate in Wistar and Wag rats, and low in DZB rats. In the 
absence of 2-mercaptoethanol  or minimal LAK activity 
was induced. Furthermore we observed that ddition of 
50 ~m indomethacin to the culture medium in the presence 
of 2-mercaptoethanol augmented the induction of LAK 
activity to some extent. In the absence of 2-mercap- 
toethanol, addition of indomethacin resulted only in low 
levels or no induction of LAK activity. We conclude that 
for optimal induction of LAK activity by IL-2 in rat spleno- 
cyte cultures 2-mercaptoethanol is essential, while in- 
domethacin can only marginally further improve this in- 
duction. 
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Introduction 
Lymphocytes can be activated in vitro by interleukin-2 
(IL-2) to kill tumour cells, which are normally not lysed by 
natural killer (NK) cells [9]. These so-called lymphokine- 
activated killer (LAK) cells can be derived from both NK 
cells and a subset of T cells [24, 27]. In order to study 
adoptive immunotherapy in a rat tumour model it is im- 
perative to determine the conditions for optimal LAK in- 
duction in vitro first. Most in vitro work on induction of 
LAK activity has been done with murine [20]and human 
[9] lymphocytes. Vujanovic et al. [31, 32] described the 
generation of LAK activity in rat lymphocytes. In these 
reports the significance of the presence of 2-mercap- 
toethanol or indomethacin  the culture medium was not 
studied, although several beneficial effects of these factors 
on various cell culture systems have been reported [3, 8]. 
Fanger et al. [7] reported the effect of various reducing 
agents on lymphocyte transformation. Click et al. [5] re- 
ported that 2-mercaptoethanol enhanced the number of 
antibody-producing cells formed by mouse spleen cells in 
culture. The enhancement was found to be due to effects of 
2-mercaptoethanol on events that occur early in the re- 
sponse; since then its beneficial effects on various cell 
culture systems have been reported. It acts as a growth-pro- 
moting agent for several cell lines [2] and is able to pro- 
mote mixed lymphocyte culture reactions in serum-free 
cultures [12, 26]. Furthermore, 2-mercaptoethanol 
functionally replaces macrophages in the primary immune 
response [4]. It is essential for the culture and proliferation 
of clones of B lymphocytes [17, 18], and in association 
with fetal calf serum it exerts a strong mitogenic activity on 
T cells [13, 23]. Its role in the induction of LAK activity 
has not been reported before. 
Indomethacin s another agent with various effects on 
lymphocyte cultures. Monocytes and macrophages may 
play an important role in the regulation of induction of 
LAK activity. Prostaglandin E2, produced by mono- 
cytes/macrophages, hasbeen reported to inhibit both the 
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induction phase and the effector phase of  LAK  cells 
[14, 15]. The production of prostaglandin E2 is blocked by 
the cyclooxygenase inhibitor indomethacin [25]. It has 
been shown that the induction of LAK  activity in vitro in 
human [16] and in murine [15] lymphocytes can be much 
higher in the presence of indomethacin, depending on the 
presence of macrophages and monocytes. In this study we 
show the importance of 2-mercaptoethanol and in- 
domethacin i  induction of LAK  activity by IL-2 in unsep- 
arated rat splenocyte cultures. 
Mater ia l s  and  methods  
Animals. Male BN (RTln), Lewis (RTll), DZB (RT1 u) and Wistar rats 
(RT1 u) were bred in our own animal-house facility. Male Wag rats 
(RTlu), a Wistar-derived strain, were purchased from Harlan/CPB 
(Zeist, The Netherlands). The rats were used at the age of 4-5 months. 
Cultum medium. As culmre medium, RPMI-1640 medium, Dutch modi- 
fication (Gibco, Paisley, Scotland), supplemented with 10% heat-inacti- 
vated fetal bovine serum (Gibco, Paisley, Scotland), 2 mM glutamine, 
50 ~tg/ml streptomycin, and 50 U/ml penicillin, designated as complete 
medium, was used. 
Experimental design. Spleens were removed aseptically and cmshed 
with the hub of a syringe in complete medium. The erythrocytes were 
removed by hypotonic lysis with buffered ammonium chloride solution 
at 37 ° C for 5 min. Splenocytes were cultured in complete medium at a 
concentration f2 × 106 cells/ml for 3-5 days in the presence of 1000 
units human recombinant IL-2 (EuroCetus, Amsterdam, The Nether- 
lands)/ml. The concentration of 2-mercaptoethanol (J. T. Baker, 
Deventer, The Netherlands) and indomethacin (Sigma Chemicals Com- 
pany, St. Louis, USA) in the splenocyte cultures was for both 50 ~tM. For 
the dose/response experiment investigating the effect of 2-mercap- 
toethanol n induction of LAK activity, the 2-mercaptoethanol concen- 
tration was varied between 50 nM and 0.2 mM. For the dose/response 
experiment on the effect of indomethacin o  induction of LAK activity, 
the indomethacin concentration was varied between 10 nM and 0.1 mM. 
51Chromium-release cytotoxicity assay. The standard NK-resistant P815 
tumour cell line, a mouse mastocytoma, and the standard NK-sensitive 
YAC-1 tumour cell line, a mouse T cell lymphoma, were used as target 
cells in 51Cr-release assays to measure LAK activity in splenocyte cul- 
tures. P815 and YAC-1 were maintained in vitro in complete medium. 
Target cells were washed once with complete medium and 10 btl packed 
cells (106 cells) were labelled for 1.5 h at 37°C with 100 gCi sodium 
[51Cr]chromate in normal saline (Amersham, UK). Cells were washed 
three times with complete medium before use, and 100 ~t151Cr-labelled 
target cells (5000 cells/well) and 100 btl effector cells at various effector- 
to-target ratios were mixed in 96-well round-bottomed microtiter plates 
(Greiner, Langenthal, Switzerland). All tests were conducted in tripli- 
cate. Plates were incubated for 4 h at 37 ° C, and centrifuged at800 rpm 
for 5 min, after which 100 btl supernatant was removed and counted for 
release of 51Cr, designated as experimental release (ER). Maximal re- 
lease (MR) of 51Cr-labelled cells was defined as the release obtained by 
the addition of 100 I.tl Triton X-100 with a concentration f 2% to 100 btl 
target cells. Spontaneous release (SR) was obtained by incubating 100 gl 
target cells with 100 gl complete medium without further additions. 
Specific lysis was calculated as follows: 
ER - SR 
specific lysis (%) = x 100 
MR - SR 
Resu l ts  
Splenocytes from male Wistar rats 4 -5  months old were 
cultured in the presence of IL-2 (1000 U/ml) for 5 days and 
then tested for induction of LAK  activity. The results of 
five independently performed experiments are shown in 
Fig. 1 A. When no 2-mercaptoethanol was present in the 
culture medium of these splenocyte cultures, no LAK ac- 
tivity could be induced by IL-2. In the presence of 50 gM 
2-mercaptoethanol, Wistar splenocytes howed induction 
of LAK  activity by IL-2 resulting in a specific lysis of 40% 
at an effector-to-target ratio of 50:1. In the absence of 
2-mercaptoethanol, addition of indomethacin resulted in a 
low level of  induced LAK activity: maximal lysis 20%. 
Optimal LAK  activity in splenocyte cultures of Wistar rats 
was induced when besides IL-2 and 2-mercaptoethanol, 
indomethacin was present in the culture medium. Specific 
lysis was then up to 10% higher. 
We investigated in different inbred rat strains, BN, 
DZB, Lewis and Wag, whether the effect of  2-mercap- 
toethanol and indomethacin on LAK induction in Wistar 
splenocytes i a general phenomenon. As shown in Fig. 1 
all strains tested showed the same pattern of LAK  induc- 
tion. Levels of  LAK  activity depended on the presence of 
2-mercaptoethanol and indomethacin. Almost no LAK in- 
duction was observed in the presence of IL-2 alone, and no 
or minimal induction when indomethacin was added. Sig- 
nificant LAK activity was only induced when 2-mercap- 
toethanol was present in the culture medium. Addition of 
indomethacin in the presence of 2-mercaptoethanol and 
IL-2 in the culture medium resulted in at least the same, or 
a higher induction of LAK  activity. Differences in the level 
of LAK  activity between the various strains were noted 
(Fig. 1). The level of  LAK  activity induced by IL-2 in the 
presence of 2-mercaptoethanol was high in BN and Lewis 
rats (maximal ysis 60%), intermediate in Wistar and Wag 
rats (maximal ysis 45%), and low in DZB rats (maximal 
lysis 30%). 
The effect of different concentrations of  2-mercap- 
toethanol (range: 50 nM-0 .2  mM) in the culture medium 
on the induction of  LAK  activity was evaluated. The re- 
sults are depicted in Fig. 2A. There appeared to be a 
threshold concentration for 2-mercaptoethanol: ptimal 
LAK  activity was induced when the 2-mercaptoethanol 
concentration was at least 5 btM. The highest concentration 
we tested was 0.2 mM 2-mercaptoethanol. We did not 
observe any negative effect of  this rather high concentra- 
tion on induction of LAK  activity. 
The effect of the concentration of  indomethacin i  the 
culture medium on induction of LAK  activity was investi- 
gated, both in the presence and in the absence of 2-mercap- 
toethanol. Splenocytes were cultured for 5 days and then 
tested for LAK  activity in a 51Cr-release assay. Figure 2B, 
C shows dose/response curves for indomethacin on the 
level of LAK  activity in Wistar and Lewis splenocyte 
cultures in the presence of 50 gM 2-mercaptoethanol. 
There is a slight optimum of induction of LAK  activity in 
the presence of 2-mercaptoethanol in Wistar splenocytes at 
an indomethacin concentration of 50 btM (Fig. 2B). Re- 
sults with Wag and BN splenocytes were similar (data not 
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Fig. 1 A -E .  Effect of 2-mercaptoethanol (50 gM) and indomethacin 
(50 gM) on induction of LAK activity in five different rat strains. The 
specific lysis in 4-h 51Cr-release assays is shown. A The mean level of 
LAK induction in Wistar splenocyte cultures as measured in five inde- 
pendent experiments. The results shown obtained with the other rat 
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strains (B -E)  are of single experiments. Splenocytes were cultured for 
5 days with IL-2 ( [] ); IL-2 + indomethacin ( +);  IL-2 + 2-mercap- 
toethanol (-X--); IL-2 + indomethacin + 2-mercaptoethanol ( [] ). E/T ratio, 
effector-to-target ratio 
tation of LAK induction at any concentration of in- 
domethacin (Fig. 2C). In the absence of 2-mercap- 
toethanol no LAK activity (Fig. 1 B, D, E) or very low 
levels of LAK activity (Fig. 1 A, C) could be induced, 
therefore no optimal concentration f indomethacin could 
be determined under these conditions (data not shown). 
All 51Cr-release assays were carried out with P815 and 
YAC-1 as target cells. We never observed ifferences be- 
tween the results obtained with these two targets. There- 
fore only data obtained with P815 are shown as it is a 
NK-resistant target. 
Discussion 
In order to study adoptive immunotherapy with LAK cells 
it is imperative to determine first the conditions for optimal 
in vitro induction of LAK activity by IL-2. We demon- 
strated the importance of 2-mercaptoethanol and in- 
domethacin the generation of LAK activity in rat spleno- 
cyte cultures. 2-Mercaptoethanol is always used in LAK 
cell cultures of mice [20] and in LAK cell cultures of rats 
[31], but its necessity for in vitro induction ofLAK activity 
has not been studied before. In human LAK cell cultures 
2-mercaptoethanol may [24] or may not [11] be added to 
the culture medium. This is in contrast with the necessity of 
its presence in the culture medium for the induction of 
LAK activity in rat splenocytes, as we have shown in this 
study. We only could induce high levels of LAK activity in 
these cultures by IL-2 in the presence of 2-mercap- 
toethanol. This difference could be related to differences in
response of lymphocytes to IL-2 between species or to the 
difference in cell composition of the source of lymphocytes 
used for induction of LAK activity. For human adoptive 
immunotherapy eripheral blood lymphocytes are the des- 
ignated source for the generation of effector cells, whereas 
in rats only sufficient numbers of effector cells for adoptive 
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Fig. 2. A Effect of the 2-mercaptoethanol c ncenlrälJon on the level of 
LAK induction in Wag rat splenocytes cultured for 3 days in the presence 
of IL-2. Concentrations of 2-mercaptoethanol: 0 (11); 50 nM (+); 
0.5 girl (-)¢-); 5 gM ([5); 50 gM (-N-); 0.1 mM (~); 0.2 mM (A). 
E/T ratio, effector-to-tm'get ratio. B, C Effect of the indomethacin con- 
centration on the induction level of LAK activity in splenocytes of a 
Wistar rat (B) and a Lewis rat (C) cultured for 5 days in the presence of 
IL-2 and 50 gM 2-mercaptoethanol. Effector-to-target ra los: 50:1 ([]); 
25:1 (-~--); 12:1 (+); 6:1 (11) 
The mechanism by which 2-mercaptoethanol i f uences 
growth of many cell cultures and of many different aspects 
of the immune response in vitro is not known. It is impor- 
tant to understand this mechanism because the same im- 
munomodu]atory effects of thiols could play a role in vivo 
[6, 33]. Several hypotheses have been suggested and 
tested. It has been reported that increased IL-2 production 
is not a mechanism by which 2-mercaptoethanol enhances 
T cell proliferation in concanavalin-A-stimulated mouse 
splenocyte cultures [22]; that 2-mercaptoethanol might in- 
crease the responsiveness of lymphocytes toavailable IL- 
2, by enhanced cystine uptake [23] or by modulation of 
endogenous IL-2 inhibitors [10] or enhancers [1]; and that 
2-mercaptoethanol may increase IL-2-independent pro- 
liferation of lymphocytes [ 19 ]. 
We have shown hefe that, just as in many other lym- 
phoid cell culture systems, 2-mercaptoethanol plays a 
strong enhancing role in the in vitro LAK induction in rat 
splenocytes. Furthermore we demonstrated that it appeared 
to have a threshold concentration i  the induction of LAK 
activity. Optimal LAK activity was induced when the 
2-mercaptoethanol c ncentration i  sp]enocyte cultures 
was at least 5 gM. We chose a concentration of 50 gM 
2-mercaptoethanol to add to splenocyte cultures to induce 
optimal LAK activity. Splenocyte cultures from all rat 
strains tested showed a dependence of LAK induction by 
IL-2 on 2-mercaptoethanol. Differences were found in the 
level of induced LAK activity in different rat strains. This 
may be due to minor differences in cell type composition 
between spleens of different strains. It has been shown by 
others that NK activity, macrophages and monocyte con- 
tent and other immunological characteristics an vary sig- 
nificantly between strains of the same species [31 ]. 
Monocytes and macrophages, which are abundantly 
present in spleen, may play an important regulatory role in 
the generation of LAK activity [28]. Several factors pro- 
duced by these cells have been described to inhibit or to 
up-regulate in vitro induction of LAK activity [21, 29, 30]. 
Prostaglandin E2is one of those factors produced by mon- 
ocytes and macrophages which has been reported to inhibit 
the induction phase as well as the effector phase of LAK 
cells [14, 15]. The production of prostaglandin E2 is 
blocked by the cyclooxygenase inhibitor indomethacin. 
We have shown in this study that inhibition by 2-mercap- 
toethanol of prostaglandin production by macrophages or
monocytes i  not very likely to be the mechanism by which 
2-mercaptoethanol enables LAK induction in unseparated 
splenocyte cultures, because indomethacin was not able to 
substitute for 2-mercaptoethanol in this culture system. 
This does not mean that prostaglandins do not play any role 
in our rat splenocyte cultures when 2-mercaptoethanol is 
present. There are several reports in which is has been 
shown that the in vitro induction of LAK activity in human 
[16] and in murine [15] lymphocytes can be rauch higher in 
the presence of indomethacin, depending on the presence 
of macrophages and monocytes. In out study we have 
shown that LAK induction could be augmented in some 
strains by the addition of indomethacin tothe culture me- 
dium, but not very drämatically. In the concentration fange 
we tested addition of indomethacin up to 0.1 mM to rat 
splenocyte cultures always resulted in higher or at least he 
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same levels, but never in lower levels of LAK induction. 
Therefore, for optimal induction of LAK activity in unsep- 
arated rat splenocytes indomethacin should be added 
routinely to the cultures. We conclude that for optimal 
induction of LAK activity by IL-2 in rat splenocyte cul- 
tures 2-mercaptoethanol is essential. Regulation of LAK 
activity seems to be rather complex. Therefore further 
analysis of this regulation in vitro and in vivo is necessary 
in order to improve the effectiveness of immunotherapy 
with IL-2 and LAK cells. 
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